儿童克罗恩病黏膜炎症无创指数(MINI)的开发与验证
基于多中心前瞻性ImageKids研究数据,开发并验证了用于评估儿童克罗恩病黏膜炎症的无创MINI指数。MINI评分低于8分识别黏膜愈合的敏感性和特异性在推导队列为88%和85%,在验证队列为84%和87%。MINI较粪便钙卫蛋白的附加获益虽小但显著,尤其对粪便钙卫蛋白100-599 μg/g的患者。
要点
- MINI指数由PCDAI排便项、ESR、粪便钙卫蛋白和CRP构成,用于无创评估儿童CD黏膜炎症。
- MINI评分低于8分识别黏膜愈合(SESCD<3)的敏感性在推导队列为88%、验证队列为84%。
- 验证队列中评分≥8分的患者90%有活动性黏膜炎症,评分低于6分时阳性预测值提高至86%。
核心结论
- 开发了可无创评估儿童克罗恩病黏膜炎症的MINI指数,识别黏膜愈合具有高敏感性和高特异性。
- MINI较粪便钙卫蛋白测量的附加获益虽小但显著,尤其对粪便钙卫蛋白100-599 μg/g的患者。
研究设计与样本
- 多中心前瞻性ImageKids研究,儿童克罗恩病患者接受回结肠镜和磁共振小肠造影检查。
- 采用混合数学判断临床计量学方法开发加权分类指数MINI,并用3个独立患者队列验证。
- 推导队列154例(年龄14.1±2.5岁,16%有黏膜愈合),验证队列168例(年龄14.2±3.9岁,36%有黏膜愈合)。
- 黏膜愈合定义为SESCD<3。
主要发现
- 多变量模型中,PCDAI排便项、红细胞沉降率和粪便钙卫蛋白水平与SESCD相关(均P<.05)。
- 加入C反应蛋白数据后开发出MINI指数。
- MINI评分低于8分识别黏膜愈合的敏感性88%、特异性85%(推导队列),敏感性84%、特异性87%(验证队列)。
- 验证队列中评分≥8分的患者90%有活动性黏膜炎症,评分低于8分的患者78%有黏膜愈合。
- 评分低于6分时阳性预测值提高至86%。
关键数值与推荐
- MINI评分<8分:识别黏膜愈合(SESCD<3)的敏感性88%、特异性85%(推导队列)。
- MINI评分<8分:识别黏膜愈合的敏感性84%、特异性87%(验证队列)。
- MINI评分≥8分:验证队列中90%的患者有活动性黏膜炎症。
- MINI评分<8分:验证队列中78%的患者有黏膜愈合。
- MINI评分<6分:阳性预测值提高至86%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Mucosal healing (MH) has become a goal of therapy for Crohn's disease (CD), but frequent endoscopies are not feasible. We aimed to develop and validate a non-invasive index to assess mucosal inflammation in children with CD. METHODS: We collected data from the multi-center prospective ImageKids study, in which children with CD underwent ileocolonoscopy with magnetic resonance enterography. We investigated the association of pediatric CD activity index (PCDAI) items and laboratory test results with the simple endoscopic score for CD (SESCD). We used these data in a blended mathematical judgmental clinimetric approach to develop a weighted categorized index to identify children with CD who have MH, which we called the MINI index. We validated the index using data from 3 independent patient cohorts. The derivation and validation cohorts included 154 and 168 children, respectively (age 14.1 ± 2.5 years and 14.2 ± 3.9 years), of whom 16% and 36% had MH (defined as SESCD<3). RESULTS: In multivariable models, the stooling item of the PCDAI, erythrocyte sedimentation rate, and level of fecal calprotectin were associated with SESCD (all P < .05). We added data on level of C-reactive protein to develop the MINI index. MINI scores below 8 identified children with MH with 88% sensitivity and 85% specificity in the derivation cohort and with 84% sensitivity and 87% specificity in the validation cohorts. Ninety percent of the patients in the validation cohort with scores of 8 or more had active mucosal inflammation, yet 78% of patients with scores below 8 had MH. Scores below 6 increase the positive predictive value to 86%. CONCLUSIONS: We developed an index to non-invasively assess mucosal inflammation in children with CD. This index, identifies children with MH with high sensitivity and specificity. The added benefit of MINI over measurement of fecal calprotectin was small but significant, especially for patients with concentrations of fecal calprotectin from 100 to 599 μg/g. ClinicalTrials.gov no: NCT01881490.
引用
- Cozijnsen MA, Ben Shoham A, Kang B, et al. Development and Validation of the Mucosal Inflammation Noninvasive Index For Pediatric Crohn's Disease. Clin Gastroenterol Hepatol. 2019. PMID: 30981008. doi:10.1016/j.cgh.2019.04.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。